Member Info for MIKODX

Not possible.

Deadstock.

Patiencebringsit - Good find, but it's a bit late for that. The judge has already approved the restructuring plans.

https://www.lse.co.uk/news/cineworld-gets-us-court-approval-to-raise-226-bln-after-bankruptcy-47qaojs0eaz98gs.html

Coulda, woulda, shoulda. Dont see this breaking £1 anytime soon.

This was announced by NICE back in 2022

2.2.2 Genedrive CYP2C19 ID Kit (Genedrive Diagnostics) The Genedrive System is a point-of-care gene amplification device used for qualitative in vitro molecular diagnostic tests. Although not yet available, the Genedrive CYP2C19 ID Kit is under development and is expected to be available to the NHS after Q1 2023.

So news is well overdue for this.

We honestly do not know what the UK Restructuring Plan contains, other than they cannot cancel existing shares through US based C11.

Tegop - Are you sure about this, and if you are do you have any similar cases where this has happened?

NICE decides WHAT the NHS Trusts are allowed to spend the NHS budget on!

the AIHL review was done under EVA....so not an actual proper NICE guidance review.....(hence why the reference to future guidance and collecting more data)

starresnstoff - Are you actually saying that because this was done via EVA that it doesn't count? Again I ask you, if this was the case why is it being rolled out in Manchester, and planned to be rolled out in other parts of the country?

Starresnstoff - Please put a sock in it, you've spoken enough claptrap to last a lifetime. NICE do not approve tests, treatments, or medicines. There job is to collect data from them to determine their sensitivity and specificity. Once all the data is collected and they are confident that the treatment is safe and accurate, they present their findings and recommendations to the NHS. Any treatment that has been recommended by NICE, must be made as an available option to the patient through the NHS.

The AIHL test has been fully recommended by NICE and is currently being rolled out in Manchester by the NHS. So what do you mean it hasn't been fully approved? It has been approved by way of recommendation from NICE.

Stockpickfree - It's as good as been approved by the NICE recomendations. It should be fully understood by now what the NICE recommendations means. If not, they need to go back and read the small print.

The FDA approval process seems to be very long-winded and I must agree we should have heard something back on that by now. Budd has a habit of going quiet for long periods and I can understand everyone's frustration on that front. Hopefully we'll hear something soon.

Maybe someone should remind them that Mr Budd is selling the AIHL test to the NHS, being rolled out as we speak. I'm sure we will have an update on how things are progressing in due course. Fully expect this will be rolled out all around the country in the coming months/years. In the meantime, I suppose I will have to listen to all the claptrap and misinformation being posted on here.

People are talking as if Genedrive is selling a bag of sweets and can basically sell to anyone now that it has been recommended by NICE. Lol, it doesn't quite work like that in the medical industry, if you dont know that you shouldn't be invested here. Most hospitals and medical centres around the world are owned by govt and large institutes. Any new technology and treatments will have to evaluated by each country, who will have their own ways of evaluating new products. Just because we have NICE approval doesn't mean we now have the green light to sell to any country. So many ignorant comments from people who dont have a clue about how the medical industry works, they just come on here and spout pure rubbish. Wish they would just sell up and get lost. That starresnstoff fella comes to mind.

WolfofWarks - The old GM was renamed to Motors liquidation and traded on the OTCBB market for pennies. That wouldn't quite work that way with the UK market as Cineworld is already trading on the lowest platform.

But it's exactly like I said, the new company couldn't use the same name, they would have to change it, and this is according to UK laws. But as this falls under the US Ch11 laws, the old stock will most likely be renamed and trade under a different name and ticker code, while the new company continues trading as Cineworld, which is exactly what the old GM did.

Hexam - If that was the case, that would mean any company during a financial crisis can say, okay we are struggling to pay our debts so what we'll do is print new shares, cancel the old ones, and continue trading under the same name. That's impossible, they would have to first wrap up the old company before creating a new one. If the new company will have a different name then they can just cancel the old shares and issue the new ones, but if they continue to trade under the same name, the old shareholders will have to be included.

So imo one of two things will happen here. Either they will go for the option I just mentioned and include the old shares via a share quota, or they will go private and pay off the current shareholders at the current share price. The company is currently valued at 12M, so paying off current holders would be no problem for the new company.

Tegop - by saying they will cancel the current shares and issue new ones, and that the secured lender will form a new board and take total control, this seems exactly the way they're going. They might not wipe out the shareholder, but the pittance the shareholder will receive, they may as well.

Question:

If Cineworld decides to go private they will obviously have to pay off the shareholders. Is it possible that they are deliberately tanking the SP, in order to take this route?

Longtermholder14 - Investing here is essentially for the long term if you want big returns. But there are still good short term gains that can be made here as well, it's about getting the timing right when selling and buying back in. That's why I love this particular share. It can be very volatile, but if your in the share long enough, you'll have a good idea when those volatile moments are going to come. I expect this to be very volatile in the coming months.

CS - Thats the case with a lot of shares but when it starts moving up, it really does fly. The chances of this ever happening again for Omega is slim to none. The days when they were hitting over a £1 they had less than half the number of shares they have now. Which will mean, if this share ever does take off again the most you can realistically hope for is half of the historical highs.

LT holders will have to average down to have any chance of recouping any losses, and even then why would you want to pump anymore money in at a time when the company is going through a transition? There was a point when I was going to average down here, but decided to wait, and glad I did. I think this will tumble some more before it starts going up again.

No I disagree, a 10% gain is very easy when it comes to AIM shares. This isn’t the FTSE 100 or 250. I’ve seen plenty AIM shares jump 100% in a day.

Dsaf - what makes you think this is going to hit the wall? Don’t just throw statements out there without any solid reasoning or facts.

Devote provides funding for R&D projects, not for products or services that have reached Production stage. So you can forget about DEVOTE funding, maybe funding from some other source like the NIHR.

50% Loss at £1 a share is the same as 50% loss at 3p a share.

That's correct, but you have greater chance of profits buying in at 3p than you do £1.